Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
468 |
|
Actual shortage: | 53 (11%) | |
Anticipated shortage: | 18 (4%) | |
Avoided shortage: | 9 (2%) | |
Resolved: | 388 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
52 (10%) |
|
Overdue reports |
13 (17%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82941 |
TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Resolved | 2019-05-06 | 2019-06-08 | 83138 |
LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-05-06 | 2019-06-28 | 83143 |
MELOXICAM | 7.5MG | TABLET | Resolved | 2019-05-30 | 2022-08-30 | 85269 |
MELOXICAM | 15MG | TABLET | Resolved | 2019-05-30 | 2022-08-30 | 85272 |
IRBESARTAN | 75MG | TABLET | Resolved | 2019-06-10 | 2019-11-28 | 86038 |
TELMISARTAN | 40MG | TABLET | Resolved | 2019-06-10 | 2019-07-20 | 86050 |
TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-06-10 | 2019-06-28 | 86053 |
SOLIFENACIN | 5MG | TABLET | Resolved | 2019-06-10 | 2019-10-10 | 86061 |
SOLIFENACIN | 10MG | TABLET | Resolved | 2019-06-10 | 2019-10-10 | 86064 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-06-19 | 2019-09-07 | 87069 |
CANDESARTAN | 4MG | TABLET | Resolved | 2019-06-19 | 2019-07-06 | 87077 |
LOVASTATIN | 20MG | TABLET | Resolved | 2019-06-27 | 2019-07-26 | 87568 |
VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-27 | 2019-07-06 | 87571 |
ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2019-07-12 | 2019-09-07 | 89173 |
LOSARTAN | 25MG | TABLET | Resolved | 2019-07-25 | 2021-05-06 | 89940 |
RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-07-30 | 2019-12-11 | 90221 |
TERBINAFINE | 250MG | TABLET | Resolved | 2019-08-06 | 2019-10-02 | 90836 |
DICLOFENAC K | 50MG | TABLET | Resolved | 2019-08-07 | 2024-03-02 | 91112 |
VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-13 | 2019-11-14 | 93859 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |